The Allotrope Foundation (AF) started as a group of pharmaceutical companies, instrument, and software vendors that set out to simplify the exchange of data in the laboratory. After a decade of work, they released products that have found adoption in various companies. Most recently, the Allotrope Simple Model (ASM) was developed to speed up and widen the adoption. As a result, the Foundation has recently added chemical companies and, importantly, is reworking its business model to lower the entry barrier for smaller companies. Here, we present the proceedings from the Allotrope Connect Fall 2023 conference and summarize the technical and organizational developments at the Foundation since 2020.

中文翻译：

---

同素异形体简单模型的兴起：2023 年秋季同素异形体连接更新

同素异形体基金会 (AF) 最初是由一群制药公司、仪器和软件供应商组成的团体，旨在简化实验室中的数据交换。经过十年的努力，他们发布的产品已被多家公司采用。最近，开发了同素异形体简单模型 (ASM)，以加速和扩大采用范围。因此，该基金会最近增加了化学公司，更重要的是，它正在重新设计其商业模式，以降低小公司的进入门槛。在这里，我们介绍 Allotrope Connect 2023 年秋季会议的记录，并总结 2020 年以来基金会的技术和组织发展。